The PURI-HF (Air Purifiers on Heart Failure) Trial
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Heart Failure
In brief
Indoor air pollution and fine mode particulate matter with an aerodynamic diameter smaller than 2.5 micrometers (PM2.5) is a major contributor to global morbidity and mortality, particularly due to cardiovascular disease. This project aims to demonstrate the efficacy, feasibility and effectiveness of portable air filters in improving indoor PM2.5 levels and improving functional capacity of heart failure patients with reduced ejection fraction in India. The findings from the project will add to existing knowledge of innovative and scalable strategies to improve environmental and cardiovascular health worldwide. The overall objective of this study is to demonstrate the efficacy, feasibility, and effectiveness of portable air filters in improving indoor PM2.5 levels and improving functional capacity of heart failure patients with reduced ejection fraction in India.
Key facts
- Study ID
- NCT05230784
- Run by
- NYU Langone Health
- People needed
- 255
- Starts
- 2024-03-06
- Expected to finish
- 2028-04-30
- Last updated by the study team
- 2026-01-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults ≥ 18 years of age diagnosed with HF with a reduced ejection fraction of ≤ 40% within the last six months in NYHA class II-IV.
You may not qualify if…
- listed for a cardiac transplant
- history of CRT device implantation in last 3 months
- on oxygen therapy
- with severe pulmonary disease
- participants unable to ambulate
Where it is running
- Centre for Chronic Disease Control (CCDC) — Thiruvananthapuram, Kerala, India (enrolling)
- All India Institute of Medical Sciences (AIIMS) — Delhi, Punjab, India (enrolling)
- Public Health Foundation of India (PHFI) — Ludhiana, Punjab, India (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.